Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, February 02, 2010

Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.